227 related articles for article (PubMed ID: 34569961)
1. Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease.
Wang Q; Dong X; Zhang R; Zhao C
J Alzheimers Dis; 2021; 84(2):505-533. PubMed ID: 34569961
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of Flavonoids against Alzheimer's Disease: Pathological Hypothesis, Potential Targets, and Structure-Activity Relationship.
Li J; Sun M; Cui X; Li C
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077418
[TBL] [Abstract][Full Text] [Related]
3. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
4. Potential of flavonoids as anti-Alzheimer's agents: bench to bedside.
Kaur R; Sood A; Lang DK; Bhatia S; Al-Harrasi A; Aleya L; Behl T
Environ Sci Pollut Res Int; 2022 Apr; 29(18):26063-26077. PubMed ID: 35067880
[TBL] [Abstract][Full Text] [Related]
5. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
6. Magnetic chrysin silica nanomaterials behavior in an amyloidogenic environment.
Nday CM; Eleftheriadou D; Jackson G
Hell J Nucl Med; 2019; 22 Suppl():42-50. PubMed ID: 30877722
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
Mullane K; Williams M
Biochem Pharmacol; 2018 Dec; 158():376-401. PubMed ID: 30273552
[TBL] [Abstract][Full Text] [Related]
8. Role of natural products for the treatment of Alzheimer's disease.
Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
[TBL] [Abstract][Full Text] [Related]
9. Total flavonoid extract from Dracoephalum moldavica L. attenuates β-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways.
Liu QS; Jiang HL; Wang Y; Wang LL; Zhang JX; He CH; Shao S; Zhang TT; Xing JG; Liu R
Life Sci; 2018 Jan; 193():214-225. PubMed ID: 29100755
[TBL] [Abstract][Full Text] [Related]
10. The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease.
Iqbal UH; Zeng E; Pasinetti GM
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664669
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of flavonoids against Alzheimer's disease-related neural dysfunctions.
Bakhtiari M; Panahi Y; Ameli J; Darvishi B
Biomed Pharmacother; 2017 Sep; 93():218-229. PubMed ID: 28641164
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of flavonoids in the management of obesity-induced Alzheimer's disease: an overview of preclinical and clinical studies.
Kothawade SM; Buttar HS; Tuli HS; Kaur G
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2813-2830. PubMed ID: 37231172
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.
Hirohata M; Ono K; Yamada M
Curr Pharm Des; 2008; 14(30):3280-94. PubMed ID: 19075706
[TBL] [Abstract][Full Text] [Related]
14. Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection.
Jiaranaikulwanitch J; Pandith H; Tadtong S; Thammarat P; Jiranusornkul S; Chauthong N; Nilkosol S; Vajragupta O
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809092
[TBL] [Abstract][Full Text] [Related]
15. Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer's disease.
Punmiya A; Prabhu A
Neurochem Int; 2023 Feb; 163():105486. PubMed ID: 36641110
[TBL] [Abstract][Full Text] [Related]
16. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
Andarzi Gargari S; Barzegar A; Tarinejad A
PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
[TBL] [Abstract][Full Text] [Related]
17. Current study on diagnosis and treatment of Alzheimer's disease by targeting amyloid b-protein.
Hua KY; Zhao WJ
Folia Neuropathol; 2023; 61(1):8-15. PubMed ID: 37114956
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Natural product for the treatment of Alzheimer's disease.
Bui TT; Nguyen TH
J Basic Clin Physiol Pharmacol; 2017 Sep; 28(5):413-423. PubMed ID: 28708573
[TBL] [Abstract][Full Text] [Related]
20. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease.
Bastianetto S; Krantic S; Quirion R
Mini Rev Med Chem; 2008 May; 8(5):429-35. PubMed ID: 18473932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
